Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Sep;16(9):1456-8.
doi: 10.3201/eid1609.100276.

Increasing incidence of mucormycosis in University Hospital, Belgium

Veroniek Saegeman  1 , Johan Maertens, Wouter Meersseman, Isabel Spriet, Eric Verbeken, Katrien Lagrou
Affiliations

Increasing incidence of mucormycosis in University Hospital, Belgium

Veroniek Saegeman et al. Emerg Infect Dis. 2010 Sep.

Abstract

To determine why incidence of mucormycosis infections was increasing in a large university hospital in Belgium, we examined case data from 2000-2009. We found the increase was not related to voriconazole use but most probably to an increase in high-risk patients, particularly those with underlying hematologic malignancies.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Incidence of mucormycosis cases in a hospital in Belgium, 2000–2009. HSCT, hematopoietic stem cell transplantation.
Figure 2
Figure 2
Specific annual incidence rate for the risk groups solid organ transplantation, hematologic disorder/malignancy, and hematopoietic stem cell transplantation (HSCT) in a hospital in Belgium, 2000–2008.
See this image and copyright information in PMC

References

    1. Bitar D, Van Cauteren D, Lanternier F, Dannaoul E, Che D, Dromer F, et al. Increasing incidence of zygomycosis (mucormycosis), France, 1997–2006. Emerg Infect Dis. 2009;15:1395–401. 10.3201/eid1509.090334 - DOI - PMC - PubMed
    1. Rees JR, Pinner RW, Hajjeh RA, Brandt ME, Reingold AL. The epidemiological features of invasive mycotic infections in the San Francisco Bay area, 1992–1993: results of population-based laboratory active surveillance. Clin Infect Dis. 1998;27:1138–47. 10.1093/clinids/27.5.1138 - DOI - PubMed
    1. Pongas GN, Lewis RE, Samonis G, Kontoyiannis DP. Voriconazole-associated zygomycosis: a significant consequence of evolving antifungal prophylaxis and immunosuppression practices. Clin Microbiol Infect. 2009;15(Suppl 5):93–7. 10.1111/j.1469-0691.2009.02988.x - DOI - PubMed
    1. Marty FM, Cosimi LA, Baden LR. Breakthrough zygomycosis after voriconazole treatment in recipients of hematopoietic stem-cell transplants. N Engl J Med. 2004;350:950–2. 10.1056/NEJM200402263500923 - DOI - PubMed
    1. Faverly D, Renard F, Drijkoningen M, Scheiden R. Breast cancer screening pathology: an assessment of the practise and needs in Belgium and Luxembourg. Virchows Arch. 2000;437:354–9. 10.1007/s004280000254 - DOI - PubMed

LinkOut - more resources